Founder of BioNTech SE, Ganymed Pharmaceuticals AG, Ci3 Management UG and TRON - Translationale Onkologie an der Universitätsmedizin der, Ugur Sahin currently is Chief Executive Officer for BioNTech SE and Managing Director at reBOOST Management GmbH (a subsidiary of BioNTech SE) and Managing Director at Medine GmbH. Dr. Sahin is also Professor at Universitätsmedizin der Johannes Gutenberg-Universität Mainz. He previously occupied the position of Chief Medical Officer for Ganymed Pharmaceuticals AG and Co-Managing Director at TRON - Translationale Onkologie an der Universitätsmedizin der. Dr. Sahin received a doctorate from Universität zu Köln.